Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11049798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical pentavalent antimony (Sb) treatment. Sb induced long-term cure in 35% (95% confidence interval [CI], 28%-42%) of those in Bihar versus 86% (95% CI, 79%-93%) of those in Uttar Pradesh. In Bihar, the center of the Indian epidemic, traditional Sb treatment should be abandoned.
Medical subject headings
- Antimony Sodium Gluconate
- Antiprotozoal Agents
- Disease Outbreaks
- Leishmaniasis, Visceral